1. Home
  2. EXOD vs NRIX Comparison

EXOD vs NRIX Comparison

Compare EXOD & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXOD
  • NRIX
  • Stock Information
  • Founded
  • EXOD 2015
  • NRIX 2009
  • Country
  • EXOD United States
  • NRIX United States
  • Employees
  • EXOD N/A
  • NRIX N/A
  • Industry
  • EXOD
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXOD
  • NRIX Health Care
  • Exchange
  • EXOD NYSE
  • NRIX Nasdaq
  • Market Cap
  • EXOD 944.6M
  • NRIX 970.1M
  • IPO Year
  • EXOD N/A
  • NRIX 2020
  • Fundamental
  • Price
  • EXOD $33.84
  • NRIX $11.63
  • Analyst Decision
  • EXOD Strong Buy
  • NRIX Strong Buy
  • Analyst Count
  • EXOD 3
  • NRIX 16
  • Target Price
  • EXOD $64.33
  • NRIX $29.56
  • AVG Volume (30 Days)
  • EXOD 141.7K
  • NRIX 954.2K
  • Earning Date
  • EXOD 08-12-2025
  • NRIX 07-09-2025
  • Dividend Yield
  • EXOD N/A
  • NRIX N/A
  • EPS Growth
  • EXOD N/A
  • NRIX N/A
  • EPS
  • EXOD 1.44
  • NRIX N/A
  • Revenue
  • EXOD $123,208,000.00
  • NRIX $88,381,000.00
  • Revenue This Year
  • EXOD $32.58
  • NRIX $34.87
  • Revenue Next Year
  • EXOD $27.75
  • NRIX N/A
  • P/E Ratio
  • EXOD $23.69
  • NRIX N/A
  • Revenue Growth
  • EXOD 71.36
  • NRIX 41.86
  • 52 Week Low
  • EXOD $12.02
  • NRIX $8.18
  • 52 Week High
  • EXOD $117.40
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • EXOD N/A
  • NRIX 47.24
  • Support Level
  • EXOD N/A
  • NRIX $11.13
  • Resistance Level
  • EXOD N/A
  • NRIX $13.00
  • Average True Range (ATR)
  • EXOD 0.00
  • NRIX 0.78
  • MACD
  • EXOD 0.00
  • NRIX -0.16
  • Stochastic Oscillator
  • EXOD 0.00
  • NRIX 14.70

About EXOD EXODUS MOVEMENT INC

Exodus Movement Inc is a self-custodial platform that connects people with the world of decentralized finance and the power of the blockchain. Available for desktop and mobile, it allows users to secure, manage and exchange cryptocurrencies like Bitcoin, Ethereum. Geographical presence in Europe, United States, the Middle East, and Africa (EMEA); Asia-Pacific (APAC); and Canada and Latin America (Other Americas).

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: